AbbottNYSE: ABT: Provides medical devices, diagnostics, and science-based nutritional products.
7+ YOEAdvanced degree in HEOR/epidemiology preferred, 7+ years HEOR/evidence generation or reimbursement experience, knowledge of US market access, strong project management, presentation and stakeholder collaboration skills.
Neurocrine BiosciencesNASDAQ: NBIX: Develops pharmaceuticals for neurological, endocrine, and psychiatric disorders.
4+ YOEAdvanced degree in HEOR/Health Economics (MPH/MS/PhD/PharmD) with 4+–6+ years pharma HEOR experience, prior managerial experience, strong data analysis and publication writing, SAS and MS Office proficiency.
Microsoft Word, Microsoft Excel, Microsoft PowerPoint, SAS
New Jersey or Pennsylvania or New York City or United States
$210k-$250k/yrRemoteFull Time
Zealand PharmaNasdaq Copenhagen: ZEAL: Develops peptide-based medicines for obesity and metabolic health.
8+ YOEAdvanced degree in HEOR/epidemiology,8+ years HEOR/RWE experience,expertise in RWD study design,evidence generation, payer engagement,external collaboration,and scientific communication.
New Jersey or Pennsylvania or New York City or United States
$210k-$250k/yrRemoteFull Time
Zealand PharmaNasdaq Copenhagen: ZEAL: Discovers and develops peptide-based medicines for metabolic and rare diseases.
8+ YOEPhD/MPH/Masters in HEOR, epidemiology or related;8+ years HEOR/RWE experience;expertise in RWD study design, economic modeling, payer evidence generation, and external publication.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
7+ YOEAdvanced degree in health economics or related field; 7+ years' experience with a Master's (5+ with PhD); HEOR strategy, HEOR leadership, HTA/regulatory knowledge, cross-functional collaboration and external engagement.
Cambridge or Morristown or United States or Puerto Rico or North America
$179k-$258k/yrOnsiteFull Time
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
7+ YOEAdvanced degree in a scientific discipline, 7+ years HEOR/health economics experience, U.S. product launch and payer evidence expertise, proficiency in HEOR methods, strong communication and cross-functional collaboration skills.
AbbottNYSE: ABT: Manufactures medical devices, diagnostics, and nutritional health products.
7+ YOEAdvanced degree (masters/PhD/MD) preferred in health economics, outcomes research or epidemiology; 7+ years HEOR/evidence generation/reimbursement experience; strong project management, communication, and commercial acumen.
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
13+ YOE13+ years HEOR experience with advanced degree (DrPH/PharmD), deep HEOR/RWE expertise, ability to lead customer-facing research, build external partnerships, and influence cross-functionally in payer and access settings.
Innovaccer: Cloud platform for healthcare data activation and clinical analytics.
4+ YOEAdvanced quantitative degree preferred,4+ years healthcare data/HEOR experience,proficiency in SAS,R,STATA or Python,knowledge of ICD/CPT/HCPCS and Medicare/Medicaid data,strong analytical and communication skills.
Compass PathwaysNASDAQ: CMPS: Develops psilocybin-based therapies for treatment-resistant mental health conditions.
3+ YOEAdvanced degree in health-related field, 2–5 years field-based and/or managed care/HEOR experience, expertise in health economics and RWE, strong payer engagement skills, valid driver's license, ability to travel 50–70%.
Rocket PharmaceuticalsNASDAQ: RCKT: Developing gene therapies for rare and life-threatening diseases.
15+ YOEAdvanced degree required; 15+ years HEOR/pricing experience in biopharma with pharmacoeconomic modeling, RWE, HTA and payer engagement; strong leadership and communication skills.
Director, HEOR Value Demonstration - Obesity & Liver (Remote)
Ridgefield, Connecticut, United States
$200k-$316k/yrRemoteFull Time
Boehringer Ingelheim: Researches and develops pharmaceutical products for humans and animals.
10+ YOEDoctorate in clinical discipline with formal HEOR training, 10+ years HEOR/managed markets experience, expertise in pharmacoeconomics, observational research, statistical methods, and US healthcare financing.
Rocket PharmaceuticalsNASDAQ: RCKT: Developing gene therapies for rare and life-threatening diseases.
15+ YOEAdvanced degree required; 15+ years HEOR/pharmacoeconomics experience in biopharma; proven pricing, access, RWE and economic modeling leadership; publication and payer-facing communication record; vendor and cross-functional leadership.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
20+ YOE20+ years in observational research and data analytics; Master’s or higher in Health Economics/HEOR; epidemiology training; drug development experience; strong cross-functional leadership.
Associate Director, HEOR, Patient-Centered Research
Cambridge, Massachusetts, United States
$154k-$230k/yrHybridFull Time
Agios PharmaceuticalsNASDAQ: AGIO: Develops small-molecule medicines for rare diseases and hematology.
7+ YOEMaster’s or doctoral degree in health services research, sociology, psychology, psychometrics, public health, or related field; at least 7 years in pharma/biotech with 5+ in patient-centered research; strong COA/PRO expertise; ability to travel ~10%.
Senior Director, Global Health Economics Outcomes Research (HEOR)
Warren, New Jersey, United States
$247k-$311k/yrHybridFull Time
PTC TherapeuticsNASDAQ: PTCT: Develops and commercializes treatments for patients with rare diseases
10+ YOEPh.D./Pharm.D./M.P.H./M.S./M.D. with 10+ years in health economics/outcomes research; payer experience; global reimbursement knowledge; strong communication; travel ~30%.
Syneos Health: Global biopharmaceutical services for clinical development and commercialization.
2+ YOE2+ years MSL industry experience, strong scientific/clinical acumen, HEOR/managed care knowledge, GI/Liver experience preferred, ability to communicate complex data to HCPs/HCDMs, travel up to 60%, valid driver’s license.